HTBX Quote, Trading Chart, Heat Biologics Inc.
home / stock / htbx / htbx quote
$7.87 Last:
-3.91% Change Percent:
$8.22 Open:
$7.87 Previous Close:
$8.35 High:
$7.72 Low:
630,191 Volume:
03/02/2021 04:55:32 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-02 | 8.22 | 7.87 | 8.35 | 7.72 | 630,191 |
| 2021-03-01 | 8.11 | 8.19 | 8.37 | 7.92 | 1,002,168 |
| 2021-02-26 | 7.98 | 7.98 | 8.13 | 7.56 | 709,497 |
| 2021-02-25 | 8.4 | 7.91 | 8.605 | 7.76 | 1,014,191 |
| 2021-02-24 | 8.37 | 8.46 | 8.93 | 8.31 | 848,588 |
| 2021-02-23 | 8.64 | 8.33 | 8.68 | 7.8 | 1,371,859 |
| 2021-02-22 | 9.45 | 9.05 | 9.6499 | 8.91 | 1,013,450 |
| 2021-02-19 | 9.42 | 9.6 | 9.82 | 9.3601 | 857,129 |
| 2021-02-18 | 9.81 | 9.31 | 10 | 9.23 | 1,051,638 |
| 2021-02-17 | 10.42 | 10.1 | 10.42 | 9.4 | 1,975,531 |
| 2021-02-16 | 11.43 | 10.69 | 11.55 | 10.5101 | 2,749,961 |
| 2021-02-15 | 11.4 | 11.43 | 12.46 | 11.05 | 1,673,311 |
| 2021-02-12 | 11.4 | 11.43 | 12.46 | 11.05 | 1,661,631 |
| 2021-02-11 | 11.28 | 11.84 | 12.28 | 10.85 | 3,449,229 |
| 2021-02-10 | 12.83 | 11.01 | 12.91 | 10.21 | 6,819,494 |
| 2021-02-09 | 16.99 | 12.54 | 17 | 11.51 | 70,278,167 |
| 2021-02-08 | 7.5124 | 8.37 | 8.47 | 7.4 | 1,913,264 |
| 2021-02-05 | 7.78 | 7.54 | 7.81 | 7.18 | 1,262,403 |
| 2021-02-04 | 7.51 | 7.61 | 7.84 | 7.31 | 1,422,482 |
| 2021-02-03 | 7.2342 | 7.46 | 7.5 | 7.0575 | 970,757 |
News, Short Squeeze, Breakout and More Instantly...
-
DURHAM, NC / ACCESSWIRE / February 12, 2021 / Heat Biologics, Inc. ("Heat") (Nasdaq:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, ...
-
Median overall survival of 24.6 months in previously treated checkpoint inhibitor naïve non-small cell lung cancer patients who received HS-110 in combination with nivolumab DURHAM, NC / ACCESSWIRE / February 9, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX) , a clinical-sta...
-
Spike specific CD8+ and CD4+ T-cell memory responses observed 30- and 60- days post vaccination DURHAM, NC / ACCESSWIRE / January 27, 2021 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX) , a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to mod...